{"result": "(\"entity\"<|>DIABETES<|>EVENT<|>Diabetes is a chronic condition that affects how the body processes blood sugar (glucose) and can lead to complications such as diabetic retinopathy and macular edema.)\n##\n(\"entity\"<|>DIABETIC RETINOPATHY<|>EVENT<|>Diabetic retinopathy is a diabetes complication that affects the eyes, characterized by damage to the blood vessels of the retina.)\n##\n(\"entity\"<|>EDEMA MACULAR DIABÉTICO<|>EVENT<|>Diabetic macular edema is a condition that involves swelling in the macula due to fluid accumulation, often associated with diabetic retinopathy.)\n##\n(\"entity\"<|>AMERICAN DIABETES ASSOCIATION<|>ORGANIZATION<|>The American Diabetes Association is a leading organization that provides information and standards of care for diabetes management and research.)\n##\n(\"entity\"<|>WILKINSON C.<|>PERSON<|>Wilkinson C. is a researcher who contributed to the proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales.)\n##\n(\"entity\"<|>ANTONETTI DA<|>PERSON<|>Antonetti DA is a researcher known for work on diabetic retinopathy and its complications.)\n##\n(\"entity\"<|>KLEIN R.<|>PERSON<|>Klein R. is a researcher who has published extensively on diabetic retinopathy and its effects on vision.)\n##\n(\"entity\"<|>GARDNER TW<|>PERSON<|>Gardner TW is a researcher who has contributed to the understanding of diabetic retinopathy and its clinical implications.)\n##\n(\"relationship\"<|>DIABETES<|>DIABETIC RETINOPATHY<|>Diabetic retinopathy is a complication that arises from diabetes, indicating a direct relationship between the two<|>9)\n##\n(\"relationship\"<|>DIABETIC RETINOPATHY<|>EDEMA MACULAR DIABÉTICO<|>Diabetic macular edema is a specific condition that can occur as a result of diabetic retinopathy<|>8)\n##\n(\"relationship\"<|>AMERICAN DIABETES ASSOCIATION<|>DIABETES<|>The American Diabetes Association provides guidelines and standards for the management of diabetes<|>7)\n##\n(\"relationship\"<|>WILKINSON C.<|>DIABETIC RETINOPATHY<|>Wilkinson C. contributed to the clinical classification of diabetic retinopathy<|>6)\n##\n(\"relationship\"<|>ANTONETTI DA<|>DIABETIC RETINOPATHY<|>Antonetti DA has researched diabetic retinopathy and its complications extensively<|>6)\n##\n(\"relationship\"<|>KLEIN R.<|>DIABETIC RETINOPATHY<|>Klein R. has published significant research on diabetic retinopathy<|>6)\n##\n(\"relationship\"<|>GARDNER TW<|>DIABETIC RETINOPATHY<|>Gardner TW has contributed to the understanding of diabetic retinopathy<|>6)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: uros lejos del centro de la mácula.\n         inicial completo y en midriasis dentro              de los 5 años posteriores al diagnóstico de diabetes.                                       B. Exudados duros en la mácula, pero sin afectación del punto central.\n         La retinopatía diabética es una complicación vascular altamente específica de la DM1 y la                                                       C. Exudados blandos en la mácula, pero sin afectación del punto central.\n         DM2, y se relaciona predominantemente con la duración de la diabetes y el nivel de control                                                      D.   Exudados blandos lejos del centro de la mácula.\n         glucémico.\n\n\n\n108                                                                                                                                                                                                                                                                                         109\n---\n                                                                                                                                                                                                                                                    DIABETES                           2\n\n\n\n         COMENTARIO                                                                                                                                      crecimiento del endotelio vascular (VEGF), serán fundamentales para iniciar la angiogéne-\n         En la tabla 6 se muestra la clasificación clínica internacional del edema macular diabético                                                     sis. Esta etapa final se conoce como retinopatía diabética proliferativa y se caracterizará\n         según el nivel de gravedad.                                                                                                                     clínicamente por la presencia de neovasos.\n                                                                                                                                                         Debido a que se estima que la retinopatía tarda al menos 5 años en desarrollarse después\n         Tabla 6. Clasificación clínica internacional del edema macular diabético según el nivel                                                         de la aparición de la hiperglucemia, los pacientes con DM1 deben someterse a un examen\n         de gravedad                                                                                                                                     ocular inicial completo y en midriasis dentro de los 5 años posteriores al diagnóstico de\n                                                                                                                                                         diabetes.\n          Nivel de gravedad                     Hallazgos en la oftalmoscopia bajo midriasis*\n          Sin EMD aparente                      Sin engrosamiento retiniano ni exudados duros en polo posterior                                          Referencias:\n                                                                                                                                                         • American Diabetes Association. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2019. Diabetes\n          EMD aparentemente presente            Aparente engrosamiento retiniano o exudados duros en polo posterior                                        Care. 2019;42(Suppl 1):S124-38.\n                                                                                                                                                         • Antonetti DA, Klein R, Gardner TW. Diabetic retinopathy. N Engl J Med. 2012;366:1227-39.\n                                                Engrosamiento retiniano o exudados duros en polo posterior:\n          EMD presente                          • Leve: distantes del centro de la mácula\n                                                • Moderado: próximos al centro de la mácula                                                          48  La exploración principal para el estudio de la mácula en la enfermedad ocular\n                                                • Grave: englobando el centro de la mácula                                                               diabética es:\n         *Los exudados duros son signo de EMD previo. El EMD se define como engrosamiento retiniano y requiere observación tridimensional\n         que se logra a través de la pupila dilatada usando lámpara de hendidura con una lente accesoria o con fotografías estéreo.                      A. La angiofluoresceingrafía retiniana.\n         Adaptado de: Wilkinson C, Ferris FL 3rd, Klein RE, Lee PP, Agardh CD, Davis M, et al. Proposed International Clinical Diabetic Retinopathy      B. La tomografía de coherencia óptica.\n         and Diabetic Macular Edema Disease Severity Scales. Ophthalmology. 2003;110:1677-82.\n                                                                                                                                                         C. La retinografía no midriática.\n         Referencias:                                                                                                                                    D.  La retinografía digital.\n         • Antonetti DA, Klein R, Gardner TW. Diabetic retinopathy. N Engl J Med. 2012;366:1227-39.\n         • Wilkinson C, Ferris FL 3rd, Klein RE, Lee PP, Agardh CD, Davis M, et al. Proposed International Clinical Diabetic Retinopathy\n           and Diabetic Macular Edema Disease Severity Scales.\n           Ophthalmology. 2003;110:1677-82.                                                                                                              COMENTARIO\n                                                                                                                                                         El edema macular diabético se define como engrosamiento de la retina y edema que afecta\n     47  Señale la opción falsa en relación con las complicaciones crónicas de la diabetes:                                                              a la mácula, y puede visualizarse mediante un examen de fondo de ojo especializado con\n                                                                                                                                                         visión estereoscópica, angiografía con fluoresceína y, más directamente, mediante tomo-\n         A. La hipertensión es un factor de riesgo de desarrollo de retinopatía.                                                                         grafía de coherencia óptica (OCT; una tecnología de imágenes láser no invasiva y de baja\n         B. El edema macular suele ocurrir después de que se produzca una retinopatía proliferativa.                                                     energía).\n         C. El incremento del VEGF se ha relacionado con la patogénesis de la retinopatía.                                                               Referencias:\n         D.  Aproximadamente el 15% de los pacientes con DM1 al diagnóstico tiene signos                                                                 • Antonetti DA,\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}